News
Nijmegen, NL, January 19, 2026 – Today we are happy to announce another great addition to the team. As per January 15, 2026 Guilhem Devillechabrolle, DVM joined Vaxxinova as Regional Manager for Europe. Guilhem previously worked in various commercial roles in the Animal Health industry in Singapore, USA and France. Guilhem will be helping us […] O post Welcome Guilhem Devillechabrolle to Vaxxinova, Europe apareceu primeiro em Vaxxinova. Read more
Willmar, USA, January 19, 2026 – Vaxxinova will be on site at the International Production & Processing Expo, connecting with poultry professionals to discuss practical, science-based solutions for today’s production challenges. From disease prevention strategies to vaccine innovation and field-level support, our team looks forward to sharing how Vaxxinova partners with producers to protect flock […] O post Vaxxinova heading to IPPE apareceu primeiro em Vaxxinova. Read more
Nijmegen, NL, January 12, 2026 – This week, we’re pleased to announce Mohammed Serry, DVM as Country Representative in Saudi Arabia. Mohammed joined Vaxxinova on January 2, 2026. Mohammed brings over 15 years of experience from the field, working as a poultry veterinarian with established companies in the region. Mohammed will strengthen our commitment to […] O post Welcome Mohammed Serry to Vaxxinova, Saudi Arabia apareceu primeiro em Vaxxinova. Read more
Nijmegen, NL, January 5, 2026 – We’re excited to welcome Merry Pradana, DVM to Vaxxinova! Merry joins us as Country Representative in Indonesia as per January 2, 2026. She brings 13 years experience in working with Key Accounts in Indonesia. Her work will help us Advancing Poultry Health in the region. Please join us in […] O post Merry Pradana joins Vaxxinova team in Indonesia apareceu primeiro em Vaxxinova. Read more
Transaction reinforces the strategic importance of Brazil and Latin America in the global expansion of the Vaxxinova group Sao Paulo, Brazil, December 15, 2025 – Vaxxinova completed the acquisition of Labovet on December 15, 2025, strengthening its presence in the Brazilian animal health market and reinforcing its growth strategy in Latin America. The transaction highlights […] O post Vaxxinova announces acquisition of Labovet and strengthens its presence in the animal health market apareceu primeiro em Vaxxinova. Read more
Nijmegen, NL, December 18, 2025 – As we celebrate the holiday season, we extend our appreciation to all customers, partners and colleagues worldwide for their continued trust and partnership. Together, we look forward to a healthy and successful year ahead. Wishing all a joyful festive season. O post Season’s Greetings apareceu primeiro em Vaxxinova. Read more
Nijmegen, NL, August 1, 2025 – We are pleased to announce that Oscar Repping will be joining Vaxxinova as Chief Operations Officer (COO) effective August 1, 2025. Oscar will succeed Marcus Conradt, who stepped down from this position earlier in the year. Oscar holds a degree in Applied Sciences and brings over 24 years of […] O post Vaxxinova Welcomes Oscar Repping as Chief Operations Officer apareceu primeiro em Vaxxinova. Read more
The Netherlands, July 9, 2025 – Today we are pleased to announce the acquisition of Deltamune (Pty) Ltd (South Africa) from Phatisa. Deltamune is a leading Animal Health company in South Africa, specialized in African livestock solutions with in-house R&D and production capabilities for licensed and autogenous vaccines, covering Sub Saharan Africa. Phatisa is a respected […] O post Deltamune & Vaxxinova Join Forces apareceu primeiro em Vaxxinova. Read more
The Netherlands, June 17, 2025 – The Avishield portfolio currently consists of eight products manufactured, marketed and sold by Dechra into 29 countries. In addition, the Dechra poultry vaccine research and development (R&D) team of 24 people based in Zagreb, Croatia, and corresponding pipeline of potential future products, will also transfer to Vaxxinova upon completion, […] O post Dechra announces sale of the Avishield® poultry vaccines portfolio to Vaxxinova apareceu primeiro em Vaxxinova. Read more
Bergen, Norway, March 24, 2025 – On March 11, at the Frisk Fisk conference in Tromsø, Norway, Vaxxinova presented advances in the development of a vaccine against Tenacibaculum finnmarkense. The presentation, given by Vaxxinova BU Aqua Diagnostics Manager Helge-Andre Erikstad, highlighted promising results from vaccine prototypes against this bacterium, including high levels of protection under […] O post Aquatic Health Innovation: Vaxxinova Advances in Tenacibaculosis Vaccine Development apareceu primeiro em Vaxxinova. Read more